Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Recordati Signs License Agreement With Nycomed
Recordati has signed a license agreement with Nycomed for the sales and marketing of silodosin in Italy. Nycomed will also co-market the product along with Recordati in Italy.
Recordati has signed a license agreement with Nycomed for the sales and marketing of silodosin in Italy. Nycomed will also co-market the product along with Recordati in Italy.
The European Medicines Agency (EMEA) has notified Cell Therapeutics (CTI) that the latter’s pixantrone is eligible to be submitted for a Marketing Authorization Application (MAA). EMEA has also
Chondrometrics and Boston Imaging Core Lab (BICL) have formed a partnership to broaden and advance their capabilities for offering imaging biomarker analysis to osteoarthritis researchers in academia and
AkzoNobel, a paints, coatings and specialty chemicals company, has posted a decline of 10% in the revenues to E3.66 billion, as compared to previous years E4.08 billion. The
Sanofi-aventis has received FDA approval for Sculptra Aesthetic (injectable poly-L-lactic acid), for the correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles. Reportedly, the
Covance has reported GAAP earnings for its second quarter ended June 30, 2009 of $0.67 per diluted share, inclusive of a $0.01 per share gain related to the
FDA has approved Roxane’s Abbreviated New Drug Application (ANDA) for its Risperidone Oral Solution, 1mg/mL. Risperidone 1 mg/ml oral solution is indicated for the treatment of schizophrenia. Risperidone
GenVec has received a Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH).
Valeant has signed a sale and purchase agreement to acquire Tecnofarma for approximately one times sales. Michael Pearson, chairman and CEO of Valeant, said: The acquisition of Tecnofarma
Danisco’s HOWARU Protect probiotic formulation seems to provide a safe and effective means to enhance the body’s natural defense, and has been clinically shown to reduce the incidence